Jared Wheat (Tag Archives)
Subscribe to PricePlow's Newsletter and Jared Wheat Alerts
DMAA Status: Done. Hi-Tech Pharmaceuticals’ Appeal Has Ended
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow […] Continue Reading →
Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma
All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.
We finally have a bit of an […] Continue Reading →
DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court
In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:
Hi-Tech appealed the ruling of district court […] Continue Reading →
FDA May Have to Return $3 MILLION Seized from Hi-Tech Pharma
It’s been a while since we’ve given an update on the ongoing series of legal battles between Hi-Tech Pharmaceuticals and the United States Federal Government, but we’re in the midst of one of the major decisions to come down over […] Continue Reading →
Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow […] Continue Reading →
The Supplement Industry 2017 Year in Review: The 10 Biggest Stories
2017 was one to remember. It was filled with incredible highs and lows that make it one of the most tumultuous years in recent memory. As 2018 dawns, we take a look back at the previous 365 days to recount […] Continue Reading →
Hi-Tech Appeals to Get its Wrongfully-Confiscated DMAA Back
Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to release the recently-confiscated DMAA. This is the last “short-term” stand to get DMAA back, outside of the greater DMAA lawsuit appeal, which is the […] Continue Reading →
Aaron Singerman Interview: Business, Supplements, and FOCUS | Episode #003
On November 6, 2016, I had the honor to interview Aaron Singerman, the successful businessman, husband, and father who owns Redcon1 and half of Prime Nutrition.
Our conversation ranged from Redcon1 updates to supplements to entrepreneurship, as […] Continue Reading →
Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??
November 15, 2017 Update: Hi-Tech has […] Continue Reading →
The Daniel Armstrong / Ying Zhang DMAA Study Scandal at University of Texas Arlington
This is part three of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article[…] Continue Reading →
